Milestone Pharmaceuticals Inc.

MIST | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.92

$0 (+0.46%)

At close: Sep 21, 2026, 4:00 PM ET

$0.92

$0 (+0.29%)

Pre-market: Sep 22, 2026, 7:00 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-63.06M	-41.52M	-59.69M	-58.39M	-42.85M	-49.97M
Depreciation & Amortization	114K	105K	92K	89K	362K	97K
Stock-Based Compensation	7.46M	5.78M	9.53M	9.05M	7.28M	4.95M
Other Working Capital	17K	2.2M	3.88M	-2.53M	1.52M	-3.61M
Other Non-Cash Items	3.76M	3.13M	2.39M	44K	368K	n/a
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.68M	3.66M	1.24M	-3.26M	1.62M	-5.81M
Operating Cash Flow	-49.04M	-28.85M	-46.42M	-52.47M	-33.22M	-50.73M
Capital Expenditures	-302K	-33K	-112K	-272K	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-82.92M	-113.55M	-137.13M	-85.85M	-15M	-90M
Sales Maturities Of Investments	94.47M	121.87M	142M	29M	85M	20M
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	11.25M	8.28M	4.76M	-57.12M	70M	-70M
Debt Repayment	n/a	n/a	50M	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	4.86M	-2.21M	458K	5.06M	48.31M
Financial Cash Flow	85.53M	32.12M	47.79M	3.09M	5.06M	73.22M
Net Cash Flow	47.73M	11.55M	6.12M	-106.51M	41.83M	-47.51M
Free Cash Flow	-49.34M	-28.88M	-46.54M	-52.74M	-33.22M	-50.73M
Adj. Free Cash Flow	-56.8M	-34.66M	-56.07M	-61.79M	-40.5M	-55.68M
Maintenance CapEx	n/a	-33K	-112K	-272K	n/a	n/a
Growth CapEx	-302K	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-49.04M	-28.88M	-46.54M	-52.74M	-33.22M	-50.73M